Relay Therapeutics, Inc. (RLAY) Return on equity 2020–2025
Relay Therapeutics, Inc. (RLAY) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-48.8%FY2025 · since FY2020: -6.9% → -48.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -48.8% | -5.3 pp |
| FY2024 | -43.4% | +2.1 pp |
| FY2023 | -45.5% | -14.9 pp |
| FY2022 | -30.6% | +10.0 pp |
| FY2021 | -40.5% | -33.7 pp |
| FY2020 | -6.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice